Evofem Biosciences (EVFM) Announces $10M Registered Direct Preferred Stock Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Morgan Stanley Downgrades Evofem Biosciences Inc (EVFM) to Underweight
October 14, 2021 4:51 AM EDTMorgan Stanley analyst Jeffrey Hung downgraded Evofem Biosciences Inc (NASDAQ: EVFM) from Equalweight to Underweight with a price target of $0.80 (from $1.00).
THe analyst comments "For Evofem, we are below on Phexxi ($2.8M vs. consensus $3.5M). Recall that managementnoted at the MS... More
